Novartis gains breast cancer indication in Canada

Health Canada has granted approval to Novartis to market Afinitor everolimus as a treatment for postmenopausal women with hormone receptorpositive HER2negative advanced breast cancer in combination wi…

---

AstraZeneca commences FALCON breast cancer trial

AstraZeneca has commenced Fulvestrant and AnastrozoLe COmpared in hormonal therapy Naïve advanced breast cancer (FALCON) trial of Faslodex (fulvestrant) injection in breast cancer patients.

---

Roche drug helped breast cancer patients survive longer

ZURICH, Aug 27 (Reuters) - Swiss drugmaker Roche Holding AG said a late-phase trial showed its T-DM1 drug significantly extended the lives of women with advanced breast cancer.

---

Afinitor’s breast cancer OK could add $1.5B to Novartis sales

Novartis ($NVS) has another notch for Afinitor's belt. The drug won a coveted indication in advanced breast cancer, after data showed it improved progression-free survival by an average of 4.6 months.

---